Mediastinal lymph node staging with spiral CT and FDG-PET in patients with non-small cell lung cancer (NSCLC). Avoidable thoracotomies Source: Annual Congress 2004 - Lung cancer: epidemiology, diagnosis, staging Year: 2004
Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 458s Year: 2004
Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer Source: Breathe, 14 (4) 342; 10.1183/20734735.027118 Year: 2018
Clinical value of 18-FDG PET-CT in mediastinal lymph node staging in non-small cell lung cancer (NSCLC) patients with previous cN0-1 on CT Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007
Features of N-staging in left-sided non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 719s Year: 2006
Endobronchial ultrasound for mediastinal restaging in non-small cell lung cancer Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019
Staging and restaging in the era of multimodality treatment Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer Year: 2006
Endobronchial ultrasound-TBNA for mediastinal restaging after neoadjuvant chemotherapy Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology Year: 2007
Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging Source: Eur Respir J 2007; 30: Suppl. 51, 430s Year: 2007
Accuracy of re-mediastinoscopy and fusion PET-CT in the assessment of lymph node (LN) downstaging after induction chemotherapy for N2 non-small cell lung cancer (NSCLC) Source: Eur Respir J 2006; 28: Suppl. 50, 602s Year: 2006
Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015
Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease? Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018 Year: 2019
Accuracy of remediastinoscopy in restaging of lung cancer Source: Breathe 2008; 5: 66 Year: 2008
Integrated FDG-PET/CT for improved T and N staging of non-small-cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006
EBUS-TBNA vs mediastinoscopy for the staging of lung cancer Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy Year: 2006
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006
Comparison of clinic and pathological staging in non-small cell lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010
The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy Source: Annual Congress 2011 - General thoracic surgery II Year: 2011